APP and glaucoma: Moreover, it has been shown that EGCG promotes the processing of amyloid precursor protein (APP) via the nontoxic α-secretase pathway [209] and reduces the formation of β-amyloid fibrils [210], which may be of particular relevance to both AD and glaucoma.